Rhenman & Partners Asset Management AB as of June 30, 2021
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 94 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| UnitedHealth (UNH) | 3.4 | $50M | 125k | 400.44 | |
| Horizon Therapeutics Pub L SHS | 3.3 | $49M | 525k | 93.64 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 3.0 | $44M | 216k | 201.63 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.7 | $39M | 220k | 177.64 | |
| Anthem (ELV) | 2.5 | $36M | 95k | 381.80 | |
| Abbvie (ABBV) | 2.4 | $36M | 320k | 112.64 | |
| Teladoc (TDOC) | 2.4 | $35M | 210k | 166.29 | |
| Medtronic SHS (MDT) | 2.3 | $34M | 273k | 124.13 | |
| CVS Caremark Corporation (CVS) | 2.2 | $32M | 380k | 83.44 | |
| Biogen Idec (BIIB) | 2.1 | $31M | 90k | 346.27 | |
| Cigna Corp (CI) | 2.1 | $31M | 131k | 237.07 | |
| Abbott Laboratories (ABT) | 2.0 | $29M | 250k | 115.93 | |
| Eli Lilly & Co. (LLY) | 1.9 | $27M | 119k | 229.52 | |
| Mirati Therapeutics | 1.8 | $27M | 165k | 161.53 | |
| Novocure Ord Shs (NVCR) | 1.8 | $27M | 120k | 221.82 | |
| Thermo Fisher Scientific (TMO) | 1.7 | $25M | 50k | 504.48 | |
| Acceleron Pharma | 1.7 | $25M | 200k | 125.49 | |
| Seagen | 1.7 | $25M | 158k | 157.88 | |
| Humana (HUM) | 1.7 | $24M | 55k | 442.73 | |
| Axonics Modulation Technolog (AXNX) | 1.6 | $24M | 380k | 63.41 | |
| Merck & Co (MRK) | 1.6 | $23M | 300k | 77.77 | |
| Veeva Sys Cl A Com (VEEV) | 1.6 | $23M | 75k | 310.95 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $23M | 135k | 169.52 | |
| Zimmer Holdings (ZBH) | 1.5 | $23M | 140k | 160.82 | |
| Boston Scientific Corporation (BSX) | 1.5 | $22M | 520k | 42.76 | |
| Guardant Health (GH) | 1.5 | $22M | 175k | 124.19 | |
| Intuitive Surgical Com New (ISRG) | 1.4 | $21M | 23k | 919.64 | |
| Gilead Sciences (GILD) | 1.4 | $21M | 300k | 68.86 | |
| Inovalon Hldgs Com Cl A | 1.4 | $20M | 600k | 34.08 | |
| Abiomed | 1.4 | $20M | 65k | 312.11 | |
| AmerisourceBergen (COR) | 1.3 | $20M | 173k | 114.49 | |
| Pfizer (PFE) | 1.3 | $20M | 500k | 39.16 | |
| Biohaven Pharmaceutical Holding | 1.3 | $20M | 200k | 97.08 | |
| Apellis Pharmaceuticals (APLS) | 1.3 | $19M | 305k | 63.20 | |
| EXACT Sciences Corporation (EXAS) | 1.3 | $19M | 155k | 124.31 | |
| Centene Corporation (CNC) | 1.3 | $19M | 260k | 72.93 | |
| Cooper Cos Com New | 1.2 | $18M | 45k | 396.27 | |
| Intra Cellular Therapies (ITCI) | 1.2 | $18M | 430k | 40.82 | |
| Nektar Therapeutics (NKTR) | 1.1 | $16M | 950k | 17.16 | |
| Accolade (ACCD) | 1.1 | $16M | 300k | 54.31 | |
| Phreesia (PHR) | 1.1 | $16M | 260k | 61.30 | |
| Hca Holdings (HCA) | 1.1 | $16M | 75k | 206.75 | |
| McKesson Corporation (MCK) | 1.0 | $15M | 78k | 191.24 | |
| Macrogenics (MGNX) | 1.0 | $15M | 545k | 26.86 | |
| Regeneron Pharmaceuticals (REGN) | 0.9 | $14M | 25k | 558.56 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $13M | 160k | 83.44 | |
| Health Catalyst (HCAT) | 0.9 | $13M | 240k | 55.51 | |
| Johnson & Johnson (JNJ) | 0.8 | $12M | 75k | 164.75 | |
| R1 Rcm | 0.8 | $12M | 550k | 22.24 | |
| Esperion Therapeutics (ESPR) | 0.8 | $12M | 572k | 21.15 | |
| Aerie Pharmaceuticals | 0.8 | $12M | 750k | 16.01 | |
| Xencor (XNCR) | 0.8 | $12M | 340k | 34.49 | |
| Becton, Dickinson and (BDX) | 0.8 | $12M | 48k | 243.19 | |
| Edwards Lifesciences (EW) | 0.8 | $11M | 110k | 103.57 | |
| 1life Healthcare | 0.7 | $11M | 330k | 33.06 | |
| Neurocrine Biosciences (NBIX) | 0.7 | $10M | 105k | 97.32 | |
| Cassava Sciences (SAVA) | 0.7 | $9.8M | 115k | 85.44 | |
| Sangamo Biosciences (SGMO) | 0.6 | $9.2M | 765k | 11.97 | |
| Baxter International (BAX) | 0.6 | $8.9M | 110k | 80.50 | |
| Bristol Myers Squibb (BMY) | 0.6 | $8.4M | 125k | 66.82 | |
| ImmunoGen | 0.5 | $8.0M | 1.2M | 6.59 | |
| Revance Therapeutics (RVNC) | 0.5 | $8.0M | 270k | 29.64 | |
| Radius Health Com New | 0.5 | $7.8M | 430k | 18.24 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $7.8M | 300k | 26.02 | |
| Alkermes SHS (ALKS) | 0.5 | $7.6M | 309k | 24.52 | |
| Essa Pharma Com New (EPIX) | 0.5 | $7.4M | 260k | 28.57 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.5 | $7.4M | 750k | 9.85 | |
| G1 Therapeutics (GTHX) | 0.5 | $7.1M | 325k | 21.94 | |
| Silk Road Medical Inc Common (SILK) | 0.5 | $7.0M | 146k | 47.86 | |
| Meiragtx Holdings (MGTX) | 0.5 | $7.0M | 450k | 15.50 | |
| Stereotaxis Com New (STXS) | 0.4 | $6.6M | 684k | 9.64 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.4 | $6.6M | 1.5M | 4.34 | |
| Shockwave Med (SWAV) | 0.4 | $6.4M | 34k | 189.73 | |
| Phathom Pharmaceuticals (PHAT) | 0.4 | $6.3M | 186k | 33.85 | |
| Zai Lab Adr (ZLAB) | 0.4 | $6.2M | 35k | 177.00 | |
| Tenet Healthcare Corp Com New (THC) | 0.4 | $5.7M | 85k | 66.99 | |
| Myovant Sciences | 0.4 | $5.7M | 250k | 22.77 | |
| Annexon (ANNX) | 0.4 | $5.6M | 250k | 22.51 | |
| Oak Street Health | 0.4 | $5.6M | 95k | 58.57 | |
| Fibrogen (FGEN) | 0.4 | $5.3M | 200k | 26.63 | |
| Viewray Adr (VRAYQ) | 0.3 | $5.1M | 775k | 6.60 | |
| Progyny (PGNY) | 0.3 | $4.7M | 80k | 59.00 | |
| Sage Therapeutics (SAGE) | 0.3 | $4.3M | 75k | 56.81 | |
| Arena Pharmaceuticals Com New | 0.3 | $4.1M | 60k | 68.20 | |
| Immunocore Hldgs Ads (IMCR) | 0.2 | $3.5M | 90k | 39.06 | |
| Innovage Hldg Corp (INNV) | 0.2 | $3.2M | 150k | 21.31 | |
| Silverback Therapeutics (SPRY) | 0.2 | $3.1M | 100k | 30.89 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $3.0M | 75k | 39.89 | |
| Glaukos (GKOS) | 0.2 | $3.0M | 35k | 84.83 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.2 | $2.8M | 100k | 28.23 | |
| Epizyme | 0.1 | $2.2M | 265k | 8.31 | |
| Deciphera Pharmaceuticals (DCPH) | 0.1 | $2.2M | 60k | 36.62 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $1.1M | 300k | 3.83 | |
| Livanova SHS (LIVN) | 0.1 | $841k | 10k | 84.10 |
